Judith M. Matthews

Chief Financial Officer, Iterum Therapeutics plc.

Companies

Eton Pharmaceuticals, Inc.Chief financial officer Jun 1, 2026 to now¹
Iterum Therapeutics plcChief financial officer May 24, 2018 to Apr 3, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Iterum Therapeutics plc8,135 shares³Mar 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 11, 2023Shares withheld for tax 2,883 shares at $0.96 of Iterum Therapeutics plc³
Mar 11, 2023Granted 6,666 shares of Iterum Therapeutics plc³
Mar 14, 2022Sold 47,132 shares at $0.38 of Iterum Therapeutics plc⁴
Mar 14, 2022Sold 63,340 shares at $0.31 of Iterum Therapeutics plc⁵
Mar 11, 2022Granted 100,000 shares of Iterum Therapeutics plc⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREton Pharmaceuticals, Inc., Chief financial officer
2
SEC EDGARIterum Therapeutics plc, Chief financial officer
3
SEC EDGARIterum Therapeutics plc shares after the filing of Mar 11, 2023
4
SEC EDGARForm 4 filed Mar 15, 2022
5
SEC EDGARForm 4 filed Mar 15, 2022